Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


08.11.2021

1 Angiology
3 J Clin Endocrinol Metab
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Angiology

  1. ZHOU K, Qin Z, Tian J, Cui K, et al
    The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
    Angiology. 2021 May 5:33197211012129. doi: 10.1177/00033197211012129.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  2. PAQUETTE M, Amyot J, Fantino M, Baass A, et al
    Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    J Clin Endocrinol Metab. 2021;106:e3473-e3482.
    PubMed         Abstract available

  3. YEN CL, Fan PC, Lin MS, Lee CC, et al
    Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156972. doi: 10.1210.
    PubMed         Abstract available

  4. STINSON SE, Jonsson AE, Lund MAV, Frithioff-Bojsoe C, et al
    Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents.
    J Clin Endocrinol Metab. 2021 Feb 17. pii: 6141463. doi: 10.1210.
    PubMed         Abstract available


    PLoS One

  5. KIM SJ, Kwon OD, Lee EJ, Ock SM, et al
    Impact of a family history of cardiovascular disease on prevalence, awareness, treatment, control of dyslipidemia, and healthy behaviors: Findings from the Korea National Health and Nutrition Examination Survey.
    PLoS One. 2021;16:e0254907.
    PubMed         Abstract available

  6. GAO H, Wang H, Shan G, Liu R, et al
    Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China.
    PLoS One. 2021;16:e0250573.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: